About Medicago
Medicago is a company based in Quebec City (Canada) founded in 1999 was acquired by Mitsubishi Tanabe Pharma in July 2013.. Medicago has raised $49.75 million across 3 funding rounds from investors including Philip Morris International, Mitsubishi Tanabe Pharma and Yorkville Advisors. Medicago operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Serum Institute of India, Vaxcyte and Generate Biomedicines, among others.
- Headquarter Quebec City, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$49.75 M (USD)
in 3 rounds
-
Latest Funding Round
$24.23 M (USD), Series B
Sep 27, 2011
-
Investors
Philip Morris International
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Mitsubishi Tanabe Pharma
(Jul 12, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Medicago
Medicago has successfully raised a total of $49.75M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $24.23 million completed in September 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $24.2M
-
First Round
First Round
(19 Sep 2008)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2011 | Amount | Series B - Medicago | Valuation |
investors |
|
| May, 2010 | Amount | Series A - Medicago | Valuation | Yorkville Advisors |
|
| Sep, 2008 | Amount | Private Equity Round - Medicago | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Medicago
Medicago has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Philip Morris International, Mitsubishi Tanabe Pharma and Yorkville Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Offers flexible capital to micro-cap and small-cap firms for growth.
|
Founded Year | Domain | Location | |
|
Multi-category tobacco products, including cigarettes and heated options, are manufactured.
|
Founded Year | Domain | Location | |
|
Innovative therapies and drugs are developed by the pharmaceutical company.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Medicago
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Medicago
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Medicago Comparisons
Competitors of Medicago
Medicago operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Serum Institute of India, Vaxcyte and Generate Biomedicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Vaccines and immuno-biological drugs for infectious diseases are manufactured.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Medicago
Frequently Asked Questions about Medicago
When was Medicago founded?
Medicago was founded in 1999 and raised its 1st funding round 9 years after it was founded.
Where is Medicago located?
Medicago is headquartered in Quebec City, Canada. It is registered at Quebec City, Quebec, Canada.
Who is the current CEO of Medicago?
Toshifumi Tada is the current CEO of Medicago.
Is Medicago a funded company?
Medicago is a funded company, having raised a total of $49.75M across 3 funding rounds to date. The company's 1st funding round was a Private Equity Round of $15.98M, raised on Sep 19, 2008.
What does Medicago do?
Founded in 1999 and based in Quebec City, Canada, Medicago operates in the biotechnology sector, focusing on influenza vaccine development. Proprietary technologies, including plant-based Proficia and Virus-Like Particles, are utilized to create candidates such as H5N1 pandemic, H1N1 for Influenza ACalifornia0409, and seasonal influenza vaccines, which are in phase 3 clinical trials. Collaborations with Viridis S.A., Genopole Bio park, and Philip Morris International support manufacturing and protein production efforts.
Who are the top competitors of Medicago?
Medicago's top competitors include Moderna, Adaptive Biotechnologies and Vaxcyte.
Who are Medicago's investors?
Medicago has 3 investors. Key investors include Philip Morris International, Mitsubishi Tanabe Pharma, and Yorkville Advisors.